Astrazeneca AZN
NYSE AZN
$184.49 +0.12 (+0.07%)
At close: Nov 13, 2026 · 4:00 PM EST

Astrazeneca (AZN) Share-based Compensation (2012 - 2013)

Updated

Astrazeneca's Share-based Compensation came in at $719 million for FY2025, up 8.9% from $660 million in FY2024.

Analysis

Astrazeneca (AZN) Share-based Compensation (2012 - 2013) Analysis & Trends

Going back to FY2015, Astrazeneca's Share-based Compensation data covers 11 years.

  • Share-based Compensation carries a five-year compound annual growth rate of 21.0% (FY2020 to FY2025).
  • The FY2025 figure represents the highest annual Share-based Compensation in data going back to FY2015.
  • Per Business Quant, earlier years put Share-based Compensation at $660 million in FY2024 (+14.0%), $579 million in FY2023 (-6.5%), $619 million in FY2022 (+0.7%) and $615 million in FY2021 (+122.0%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 200.00 Mn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 357.00 Mn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 160.00 Mn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 369.00 Mn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 128.00 Mn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 234.00 Mn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 362.00 Mn
10 Vertex Pharmaceuticals 136.55 Bn 104.28 Bn 2.91 Bn 174.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 -568.00 Mn
Dec 31, 2012 -597.00 Mn
API Access

Astrazeneca Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=AZN&period=max&api_key=YOUR_API_KEY